Fly Amanita

Fly Amanita

Created using Figma
Created using Figma
For the last 3 years Fly Amanita has produced and sold dried Amanita Muscaria (aka Fly Agaric) mushrooms worldwide. Their experience in this fungus market has disclosed two new business opportunities - pharmaceutics demand for chemical compounds such as Muscimol, Ibotenic acid, and Muscarine, and possible rehabilitation applications in healthcare. Consequently, Fly Amanita aims to produce and meet the demand for these compounds that can be extracted for the Amanita Muscaria mushrooms.
The company is also determined to invest in the research of Amanita Muscaria related healthcare applications for rehabilitation of chronic pain, insomnia, menstrual pain, post-traumatic stress, lack of confidence, self-esteem, productivity, depression, and many more. Once those applications are found Fly Amanita plans to establish the first rehabilitation center in the EU for such treatments.
Apr 26, 2021
May 31, 2021
100% completed
Raised funds - no Data
Goal 500 000.00 USD
Cap 500 000.00 USD
Token Details
Total supply
Accepted Currencies
Min Contribution
Company Details
Registered Company Name
Fly Amanita
Registered Country
Company Founded
Apr 14, 2021
Additional Details
BInance Smart Chain

About Fly Amanita

Welcome to our online amanita muscaria shop.

We're a family that LOVES Amanita and wants to share the goodness and powerful healing properties of the shroom with the rest of the world. We're truly passionate about what we do because we know it can make a big difference to some people. Picking the mushrooms, drying them, storing them and even using it - we do everything ourselves. We've spent 4 years of studying multiple language literature and made hundreds of experiments to become experts in the field. Our conscious foraging process, immediate drying and safe storage guarantee a product with excellent colour, strong smell, and good taste. Amanita Muscaria has a lot of variations and we're proud to say that we offer 6 of them in our store.

Our priority is to have the best product, educate people about Amanita Muscaria and help those, who need help with this natural remedy

Fly Amanita Roadmap

  • Q2 2021

  • Private sales.
    Public sales. 3 rounds.
  • Q2 - Q3 2021

  • Integrate FLY payments to the Fly Amanita e-shop.
  • Q3 - Q4 2021

  • Start producing and selling chemical compounds (Muscimol, Ibotenic acid and Muscarine) to the pharmaceutical market.
    List FLY in staking projects (there's already a secured deal for that with Bitlocus exchange).
  • Q1 - Q2 2022

  • Assemble a team of experts and volunteers.
    Conduct extensive research and tests for Amanita Muscaria's application in healthcare.
  • Read More
  • Milestone 3 (Application & Rehab center)

  • Date TBA (depends on research results) - start offline and online supervisory healing application service.
    Date TBA - establish a rehabilitation center (in Lithuania, EU).


2 643
30 Days Growth:

Fly Amanita Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Arunas Siuksteris
Jurgita Mitkeviciene
Production Manager
Guste Gikaraite
Business Development Manager
Tadas Varanauskas
Blockchain Developer


Verified 25%

Attention. There is a risk that unverified members are not actually members of the team

Baiba Baika

12 ICOs

$52 209 956

Arturas Svirskis

28 ICOs

$6 954 875

Timo Trippler
Mofassair Hossain

Fly Amanita Interviews

Arturas Svirskis
As a team member, сan you tell us about your role in the ICO project?
I am responsible with fundraising activities and overall consultancy how to optimize processes in marketing and business development
What do you think about idea?
This idea is not typical for the crypto space, but many crypto investors can benefit out of it by making money
5.0 8
ICO Profile Vision Activity Potential Product Team
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.